In another retrospective study of 148 consecutive COVID-19 cases, the incidence rates of tests involved in liver function elevation included ALT (18.2%), AST (21.6%), LDH (35.1%), GGT (17.6%), ALP (4.1%), and total bilirubin (6.1%) (24). This evidence concerns the gene GPT and COVID-19.